These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 23274658
1. Pharmacokinetics and pharmacodynamics of ASP2151, a helicase-primase inhibitor, in a murine model of herpes simplex virus infection. Katsumata K, Chono K, Kato K, Ohtsu Y, Takakura S, Kontani T, Suzuki H. Antimicrob Agents Chemother; 2013 Mar; 57(3):1339-46. PubMed ID: 23274658 [Abstract] [Full Text] [Related]
2. Characterization of virus strains resistant to the herpes virus helicase-primase inhibitor ASP2151 (Amenamevir). Chono K, Katsumata K, Kontani T, Shiraki K, Suzuki H. Biochem Pharmacol; 2012 Aug 15; 84(4):459-67. PubMed ID: 22687623 [Abstract] [Full Text] [Related]
3. Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor. Yajima M, Yamada H, Takemoto M, Daikoku T, Yoshida Y, Long T, Okuda T, Shiraki K. Antiviral Res; 2017 Mar 15; 139():95-101. PubMed ID: 28027917 [Abstract] [Full Text] [Related]
4. Effect of ASP2151, a herpesvirus helicase-primase inhibitor, in a guinea pig model of genital herpes. Katsumata K, Chono K, Sudo K, Shimizu Y, Kontani T, Suzuki H. Molecules; 2011 Aug 25; 16(9):7210-23. PubMed ID: 21869749 [Abstract] [Full Text] [Related]
5. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2. Chono K, Katsumata K, Kontani T, Kobayashi M, Sudo K, Yokota T, Konno K, Shimizu Y, Suzuki H. J Antimicrob Chemother; 2010 Aug 25; 65(8):1733-41. PubMed ID: 20534624 [Abstract] [Full Text] [Related]
6. Antiviral efficacy of the helicase-primase inhibitor amenamevir in murine models of severe herpesvirus infection. Katsumata K, Chono K, Suzuki H. Biochem Pharmacol; 2018 Dec 25; 158():201-206. PubMed ID: 30365949 [Abstract] [Full Text] [Related]
19. Single amino acid substitutions in the HSV-1 helicase protein that confer resistance to the helicase-primase inhibitor BAY 57-1293 are associated with increased or decreased virus growth characteristics in tissue culture. Biswas S, Jennens L, Field HJ. Arch Virol; 2007 Apr 25; 152(8):1489-500. PubMed ID: 17404685 [Abstract] [Full Text] [Related]
20. Amenamevir, a Helicase-Primase Inhibitor, for the Optimal Treatment of Herpes Zoster. Shiraki K, Yasumoto S, Toyama N, Fukuda H. Viruses; 2021 Aug 05; 13(8):. PubMed ID: 34452412 [Abstract] [Full Text] [Related] Page: [Next] [New Search]